{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,30]],"date-time":"2026-07-30T04:59:29Z","timestamp":1785387569039,"version":"3.55.0"},"reference-count":34,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2026,7,30]],"date-time":"2026-07-30T00:00:00Z","timestamp":1785369600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Digit. Health"],"abstract":"<jats:sec>\n                    <jats:title>Introduction<\/jats:title>\n                    <jats:p>Due to complex medication regimens, suboptimal medication adherence is common among people with Parkinson\u2019s disease (PwP), leading to poor symptom control. Medication reminder technology, and a deeper understanding of individual\u2019s medication experiences and behaviours offer promising solutions, but these factors need to be explored in PwP. An online survey was developed to identify the current potential use of medication reminder technology in PwP; determine the essential features of the ideal medication reminder technology; compare feature preferences between current medication reminder technology users and non-users; and Explore Respondents Medication Experiences and Behaviour.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>The survey was open to individuals over 18, with a PD diagnosis and taking oral PD medication. The survey consisted of 51 primary questions exploring PwP medication experiences and behaviours; current\/potential use of medication reminder technology; and designing ideal medication reminder technology. Descriptive statistics, and statistical tests compared questionnaire responses. To categorise free-text responses, inductive and deductive content analysis was performed.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Data from 283 PwP (median age: 65 years, 46% female) was analysed. Thirty-four percent were non-adherent to their PD medication regimen, and respondents with more negative medication beliefs and perceived medication complexity had worse medication adherence. Fifty percent of respondents already used medication reminder technology, with these respondents most commonly using smartphones (72%). Respondents who already used medication reminder technology scored significantly higher on the medication adherence rating scale (MARS-5). When choosing the ideal medication reminder technology, smartwatches were the preferred device (57%). When designing the ideal medication reminder smartwatch, no features were deemed \u2018essential\u2019 to all respondents, with great heterogeneity in preferences. Overall, smartwatch usability and functionality was more important to respondents than appearance, and current users of reminder technology placed greater importance on smartwatch usability than non-users.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Discussion<\/jats:title>\n                    <jats:p>Medication reminder technology, such as smartwatches, may support medication adherence in PwP, but this technology must be personalised to user needs, and developed with an emphasis on usability and functionality, over aesthetics. When developing this technology, PwP should be included as co-developers, and the process should be iterative. However, reminder technology alone may not sufficiently support adherence, and additional patient-related factors need to be overcome.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.3389\/fdgth.2026.1839031","type":"journal-article","created":{"date-parts":[[2026,7,30]],"date-time":"2026-07-30T04:22:02Z","timestamp":1785385322000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":0,"title":["Exploring medication experiences, behaviours, and reminder technology preferences in people with Parkinson's disease: a survey"],"prefix":"10.3389","volume":"8","author":[{"given":"Emma","family":"Packer","sequence":"first","affiliation":[{"name":"Translational and Clinical Research Institute, Faculty of Medical Sciences, Newcastle University","place":["Newcastle upon Tyne, United Kingdom"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"H\u00e9lo\u00efse","family":"Debelle","sequence":"additional","affiliation":[{"name":"Translational and Clinical Research Institute, Faculty of Medical Sciences, Newcastle University","place":["Newcastle upon Tyne, United Kingdom"]},{"name":"Research Institute for Sport and Exercise Sciences, Liverpool John Moores University","place":["Liverpool, United Kingdom"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Annette","family":"Hand","sequence":"additional","affiliation":[{"name":"School of Healthcare and Nursing Science, Northumbria University","place":["Newcastle upon Tyne, United Kingdom"]},{"name":"The Newcastle Upon Tyne Hospitals NHS Foundation Trust","place":["Newcastle upon Tyne, United Kingdom"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lynn","family":"Rochester","sequence":"additional","affiliation":[{"name":"Translational and Clinical Research Institute, Faculty of Medical Sciences, Newcastle University","place":["Newcastle upon Tyne, United Kingdom"]},{"name":"The Newcastle Upon Tyne Hospitals NHS Foundation Trust","place":["Newcastle upon Tyne, United Kingdom"]},{"name":"National Institute for Health and Care Research (NIHR) Newcastle Biomedical Research Centre (BRC), Newcastle University, Campus for Ageing and Vitality","place":["Newcastle upon Tyne, United Kingdom"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alison J.","family":"Yarnall","sequence":"additional","affiliation":[{"name":"Translational and Clinical Research Institute, Faculty of Medical Sciences, Newcastle University","place":["Newcastle upon Tyne, United Kingdom"]},{"name":"The Newcastle Upon Tyne Hospitals NHS Foundation Trust","place":["Newcastle upon Tyne, United Kingdom"]},{"name":"National Institute for Health and Care Research (NIHR) Newcastle Biomedical Research Centre (BRC), Newcastle University, Campus for Ageing and Vitality","place":["Newcastle upon Tyne, United Kingdom"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lisa","family":"Alcock","sequence":"additional","affiliation":[{"name":"Translational and Clinical Research Institute, Faculty of Medical Sciences, Newcastle University","place":["Newcastle upon Tyne, United Kingdom"]},{"name":"National Institute for Health and Care Research (NIHR) Newcastle Biomedical Research Centre (BRC), Newcastle University, Campus for Ageing and Vitality","place":["Newcastle upon Tyne, United Kingdom"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Silvia","family":"Del Din","sequence":"additional","affiliation":[{"name":"Translational and Clinical Research Institute, Faculty of Medical Sciences, Newcastle University","place":["Newcastle upon Tyne, United Kingdom"]},{"name":"National Institute for Health and Care Research (NIHR) Newcastle Biomedical Research Centre (BRC), Newcastle University, Campus for Ageing and Vitality","place":["Newcastle upon Tyne, United Kingdom"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2026,7,30]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"108085","DOI":"10.1016\/j.neuropharm.2020.108085","article-title":"New hopes for disease modification in Parkinson\u2019s disease","volume":"171","author":"Poewe","year":"2020","journal-title":"Neuropharmacology"},{"key":"B2","doi-asserted-by":"publisher","first-page":"100125","DOI":"10.1016\/j.prdoa.2021.100125","article-title":"Natural history and patterns of treatment change in Parkinson\u2019s disease: a retrospective chart review","volume":"6","author":"Navaratnam","year":"2022","journal-title":"Clin Park Relat Disord"},{"key":"B3","doi-asserted-by":"publisher","first-page":"1248","DOI":"10.1002\/mds.27372","article-title":"International Parkinson and movement disorder society evidence-based medicine review: update on treatments for the motor symptoms of Parkinson\u2019s disease","volume":"33","author":"Fox","year":"2018","journal-title":"Mov Disord"},{"key":"B4","doi-asserted-by":"publisher","first-page":"799","DOI":"10.3389\/fneur.2019.00799","article-title":"Adherence to pharmacotherapy in patients with Parkinson\u2019s disease taking three and more daily doses of medication","volume":"10","author":"Straka","year":"2019","journal-title":"Front Neurol"},{"key":"B5","doi-asserted-by":"publisher","first-page":"514","DOI":"10.1002\/jac5.1382","article-title":"Digital health implications for clinical pharmacists services: a primer on the current landscape and future concerns","volume":"4","author":"D Aungst","year":"2021","journal-title":"JACCP"},{"key":"B6","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1186\/s12984-021-00874-8","article-title":"It\u2019s not about the capture, it\u2019s about what we can learn\": a qualitative study of experts\u2019 opinions and experiences regarding the use of wearable sensors to measure gait and physical activity","volume":"18","author":"Keogh","year":"2021","journal-title":"J Neuroeng Rehabil"},{"key":"B7","doi-asserted-by":"publisher","first-page":"1111260","DOI":"10.3389\/fneur.2023.1111260","article-title":"Feasibility and usability of a digital health technology system to monitor mobility and assess medication adherence in mild-to-moderate Parkinson\u2019s disease","volume":"14","author":"Debelle","year":"2023","journal-title":"Front Neurol"},{"key":"B8","doi-asserted-by":"publisher","first-page":"5169","DOI":"10.3390\/s19235169","article-title":"Long-Term home-monitoring sensor technology in patients with Parkinson\u2019s disease\u2014acceptance and adherence","volume":"19","author":"Botros","year":"2019","journal-title":"Sensors"},{"key":"B9","doi-asserted-by":"publisher","first-page":"107349","DOI":"10.1016\/j.parkreldis.2025.107349","article-title":"A pilot interventional study on feasibility and effectiveness of the CUE1 device in Parkinson\u2019s disease","volume":"133","author":"Azoidou","year":"2025","journal-title":"Parkinsonism Relat Disord"},{"key":"B10","doi-asserted-by":"publisher","first-page":"e0000225","DOI":"10.1371\/journal.pdig.0000225","article-title":"Feasibility and patient acceptability of a commercially available wearable and a smart phone application in identification of motor states in Parkinson\u2019s disease","volume":"2","author":"Liikkanen","year":"2023","journal-title":"PLoS Digit Health"},{"key":"B11","doi-asserted-by":"publisher","first-page":"4957","DOI":"10.3390\/s23104957","article-title":"Co-Designing digital technologies for improving clinical care in people with Parkinson\u2019s disease: what did we learn?","volume":"23","author":"Monje","year":"2023","journal-title":"Sensors (Basel)"},{"key":"B12","doi-asserted-by":"publisher","first-page":"963","DOI":"10.1111\/ijcp.12439","article-title":"Adherence therapy improves medication adherence and quality of life in people with Parkinson\u2019s disease: a randomised controlled trial","volume":"68","author":"Daley","year":"2014","journal-title":"Int J Clin Pract"},{"key":"B13","doi-asserted-by":"publisher","first-page":"e34","DOI":"10.2196\/jmir.6.3.e34","article-title":"Improving the quality of web surveys: the checklist for reporting results of internet E-surveys (CHERRIES)","volume":"6","author":"Eysenbach","year":"2004","journal-title":"J Med Internet Res"},{"key":"B14","doi-asserted-by":"publisher","first-page":"1281","DOI":"10.1111\/bcp.14193","article-title":"The medication adherence report scale: a measurement tool for eliciting patients\u2019 reports of nonadherence","volume":"86","author":"Chan","year":"2020","journal-title":"Br J Clin Pharmacol"},{"key":"B15","doi-asserted-by":"publisher","first-page":"805","DOI":"10.1080\/08870449708406741","article-title":"The PDQ-8: development and validation of a short-form Parkinson\u2019s disease questionnaire","volume":"12","author":"Jenkinson","year":"1997","journal-title":"Psychol Health"},{"key":"B16","doi-asserted-by":"publisher","first-page":"383","DOI":"10.3233\/JPD-150765","article-title":"Development and validation of the Parkinson\u2019s disease medication beliefs scale (PD-rx)","volume":"6","author":"Fleisher","year":"2016","journal-title":"J Parkinsons Dis"},{"key":"B17","doi-asserted-by":"publisher","first-page":"499","DOI":"10.1007\/s11136-010-9777-3","article-title":"Quality of life in Parkinson\u2019s disease patients: validation of the short-form eight-item Parkinson\u2019s disease questionnaire (PDQ-8) in Taiwan","volume":"20","author":"Huang","year":"2011","journal-title":"Qual Life Res"},{"key":"B18","doi-asserted-by":"publisher","first-page":"387","DOI":"10.1080\/08870446.2019.1672873","article-title":"Psychological predictors of adherence to oral hypoglycaemic agents: an application of the ProMAS questionnaire","volume":"35","author":"Vluggen","year":"2020","journal-title":"Psychol Health"},{"key":"B19","doi-asserted-by":"publisher","first-page":"e27418","DOI":"10.2196\/27418","article-title":"The views and needs of people with Parkinson disease regarding wearable devices for disease monitoring: mixed methods exploration","volume":"6","author":"Kenny","year":"2022","journal-title":"JMIR Form Res"},{"key":"B20","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1007\/s40263-014-0220-0","article-title":"Medication adherence in patients with Parkinson\u2019s disease","volume":"29","author":"Malek","year":"2015","journal-title":"CNS Drugs"},{"key":"B21","doi-asserted-by":"publisher","first-page":"826","DOI":"10.1002\/mds.22112","article-title":"Adherence to antiparkinson medication in a multicenter European study","volume":"24","author":"Grosset","year":"2009","journal-title":"Mov Disord"},{"key":"B22","volume-title":"Effectiveness of Technology-Assisted Medication Reminder Systems in Neurodegenerative Diseases: Systematic Review and Meta-analysis. Universal Access in Human-Computer Interaction","author":"Tseng","year":"2024"},{"key":"B23","doi-asserted-by":"publisher","first-page":"e18073","DOI":"10.2196\/18073","article-title":"A prospective study of usability and workload of electronic medication adherence products by older adults, caregivers, and health care providers","volume":"22","author":"Patel","year":"2020","journal-title":"J Med Internet Res"},{"key":"B24","doi-asserted-by":"publisher","first-page":"3821","DOI":"10.1007\/s00415-022-11014-0","article-title":"Undetected ophthalmological disorders in Parkinson\u2019s disease","volume":"269","author":"Borm","year":"2022","journal-title":"J Neurol"},{"key":"B25","year":"2016"},{"key":"B26","doi-asserted-by":"publisher","DOI":"10.1038\/s41531-016-0003-z","article-title":"Using a smartphone-based self-management platform to support medication adherence and clinical consultation in Parkinson\u2019s disease","volume":"3","author":"Lakshminarayana","year":"2017","journal-title":"NPJ Parkinsons Dis"},{"key":"B27","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1186\/1471-2377-7-20","article-title":"Effect of educational intervention on medication timing in Parkinson\u2019s disease: a randomized controlled trial","volume":"7","author":"Grosset","year":"2007","journal-title":"BMC Neurol"},{"key":"B28","doi-asserted-by":"publisher","first-page":"197","DOI":"10.3233\/JPD-230205","article-title":"Real-World evaluation of the feasibility, acceptability and safety of a remote, self-management Parkinson\u2019s disease care pathway: a healthcare improvement initiative","volume":"14","author":"Kehagia","year":"2024","journal-title":"J Parkinsons Dis"},{"key":"B29","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1111\/ijpp.12532","article-title":"Medication information needs of people with Parkinson\u2019s disease and their carers: a qualitative study using an online discussion forum","volume":"27","author":"Parsons","year":"2019","journal-title":"Int J Pharm Pract"},{"key":"B30","doi-asserted-by":"publisher","first-page":"1919","DOI":"10.2147\/PPA.S473991","article-title":"A qualitative study on perspectives of Parkinson\u2019s disease medications: insights from patient focus groups","volume":"18","author":"Richards","year":"2024","journal-title":"Patient Prefer Adherence"},{"key":"B31","year":"2022"},{"key":"B32","doi-asserted-by":"publisher","first-page":"145","DOI":"10.2165\/0002512-200926020-00006","article-title":"Challenges of treatment adherence in older patients with Parkinson\u2019s disease","volume":"26","author":"Bainbridge","year":"2009","journal-title":"Drugs Aging"},{"key":"B33","year":""},{"key":"B34","year":""}],"container-title":["Frontiers in Digital Health"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fdgth.2026.1839031\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,30]],"date-time":"2026-07-30T04:22:03Z","timestamp":1785385323000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fdgth.2026.1839031\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,30]]},"references-count":34,"alternative-id":["10.3389\/fdgth.2026.1839031"],"URL":"https:\/\/doi.org\/10.3389\/fdgth.2026.1839031","relation":{},"ISSN":["2673-253X"],"issn-type":[{"value":"2673-253X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,30]]},"article-number":"1839031"}}